跳至主要内容
临床试验/NCT03824652
NCT03824652招募中2 期

WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy

Stephen Freedland1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2019年4月22日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
50
试验地点
1
主要终点
Mean difference in prostatic tissue Ki67 expression from baseline biopsy to RP

研究概览

简要总结

This is a randomized control trial testing the effect of walnut supplementation on prostate cancer progression in 50 men with biopsy confirmed prostate cancer and planning to undergo RP. Patients consented to the study will be randomly assigned to either continue their usual diets (control arm) or to the walnut arm for 4-10 weeks depending on the window between their consent date and the date for RP.

详细描述

The overall objective of this study is to test the effect of walnuts added to a usual diet on prostate cancer progression as measured by Ki67 expression in the prostate tissues. Subjects will be randomized 1:1 to usual diet or usual diet with the addition of 2 ounces of walnuts daily. The baseline visit will occur in conjunction with a standard of care visit post-biopsy, the intervention period will range from 4-10 weeks dependent upon the scheduled date of the standard of care radical prostatectomy (RP), and the final visit will occur in conjunction with a standard of care visit prior to RP.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Pathologically confirmed prostate adenocarcinoma.
  • Diagnostic biopsy cores with ≥10 cores with each core examined separately to determine exact tumor location.
  • Biopsy grade group 2 or higher (Gleason ≥7).
  • Planning to undergo RP.
  • Willing to adhere to a usual diet with the possible addition of 2 oz of walnuts per day.
  • Reads, writes, and understands English.
  • Age 18 or older

排除标准

  • Allergy to nuts.
  • History of receiving hormone therapy or antiandrogen therapy.
  • Use of 5-alpha reductase inhibitors in the past 6 months.
  • Prior prostate radiotherapy (external beam or brachytherapy) or prior prostate cryotherapy.
  • Currently enrolled in a modified diet/weight loss program and/or taking dietary supplements that contain omega-3s (e.g., fish oil).
  • Other active malignancy, excluding basal cell carcinoma or squamous cell carcinoma
  • Significant co-morbidities (e.g., cardiac, pulmonary, liver disease, alcohol/drug addiction, malabsorption syndromes), that in the opinion of the study physician make the patient ineligible.
  • Individuals with psychological/mental conditions which can affect the consent process and/or their adherence to the protocol.

研究组 & 干预措施

Usual Diet + Walnuts

Experimental

Usual diet with the addition of two ounces of walnuts daily, phone counseling with dietitian, for 4-10 weeks

干预措施: walnuts (Other)

Usual Diet + Walnuts

Experimental

Usual diet with the addition of two ounces of walnuts daily, phone counseling with dietitian, for 4-10 weeks

干预措施: usual diet (Other)

Usual Diet + Walnuts

Experimental

Usual diet with the addition of two ounces of walnuts daily, phone counseling with dietitian, for 4-10 weeks

干预措施: phone counseling with dietitian (Other)

Usual Diet

Active Comparator

Usual diet for 4-10 weeks

干预措施: usual diet (Other)

结局指标

主要结局

Mean difference in prostatic tissue Ki67 expression from baseline biopsy to RP

时间窗: 10 weeks

次要结局

  • Mean difference in prostatic tissue oxidative stress from baseline biopsy to RP(10 weeks)
  • Mean difference in prostatic tissue inflammation from baseline biopsy to RP(10 weeks)

研究者

发起方
Stephen Freedland
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Stephen Freedland

Professor, Surgery

Cedars-Sinai Medical Center

研究点 (1)

Loading locations...

相似试验